ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12247 recruiting trials
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
👨⚕️ Catherine THIEBLEMONT, Prof. Dr., Hôpital Saint-Louis📍 13 sites📅 Started Jun 2024View details ↗
Effectiveness and Implementation of Text Messaging to Improve HIV Testing in Adolescents
Protein Quality of Fava Bean and Honey Chlorella in Humans
RecruitingNCT06430021 ↗
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
RecruitingNCT06411626 ↗
Home Reported Outcomes in PNH
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →